Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Decision Support for Women With Breast Cancer
Decision Support for Women With Breast Cancer
Status: Enrolling
Updated:  10/4/2011
Johns Hopkins Hosp
mi
from
Baltimore, MD
Decision Support for Women With Breast Cancer
Decision Support for Women With Breast Cancer
Status: Enrolling
Updated: 10/4/2011
Johns Hopkins Hosp
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Phase I Study of Pazopanib in Combination With Vinorelbine in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer
Status: Enrolling
Updated:  10/19/2011
Northwestern University, Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Phase I Study of Pazopanib in Combination With Vinorelbine in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer
Status: Enrolling
Updated: 10/19/2011
Northwestern University, Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
Click here to add this to my saved trials
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To Prospectively Evaluate the Potential for Simple, Effective Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Status: Enrolling
Updated:  10/25/2011
Stanford University School of Medicine
mi
from
Stanford, CA
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To Prospectively Evaluate the Potential for Simple, Effective Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Status: Enrolling
Updated: 10/25/2011
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer
A Phase II Neoadjuvant Study of RAD001 (Everolimus) in Combination With Paclitaxel and Trastuzumab For Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated:  10/31/2011
University of Kansas Medical Center
mi
from
Kansas City, KA
A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer
A Phase II Neoadjuvant Study of RAD001 (Everolimus) in Combination With Paclitaxel and Trastuzumab For Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated: 10/31/2011
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Moderating the Negative Impact of Abnormal Screening Mammograms
Moderating the Negative Impact of Abnormal Screening Mammograms
Status: Enrolling
Updated:  11/28/2011
University of WI Comprehensive Cancer Center and UW Health Clinics
mi
from
Madison, WI
Moderating the Negative Impact of Abnormal Screening Mammograms
Moderating the Negative Impact of Abnormal Screening Mammograms
Status: Enrolling
Updated: 11/28/2011
University of WI Comprehensive Cancer Center and UW Health Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Breastlink Med Group Inc
mi
from
Long Beach, CA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Breastlink Med Group Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Advanced Medical Specialties
mi
from
Miami, FL
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Advanced Medical Specialties
mi
from
Miami, FL
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Advanced Breast Care
mi
from
Marietta, GA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Advanced Breast Care
mi
from
Marietta, GA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Missouri Cancer Associates
mi
from
Columbia, MO
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Missouri Cancer Associates
mi
from
Columbia, MO
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Breast Care
mi
from
Las Vegas, NV
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Breast Care
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Morristown Memorial Hospital
mi
from
Morristown, NJ
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Beth Israel Med Ctr
mi
from
New York, NY
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
OU Medical Center
mi
from
Oklahoma City, OK
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
OU Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Breast Care Specialists, P.C.
mi
from
Allentown, PA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Breast Care Specialists, P.C.
mi
from
Allentown, PA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Breast Clinic of Memphis
mi
from
Germantown, TN
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Breast Clinic of Memphis
mi
from
Germantown, TN
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Advantage Clinical Research
mi
from
Nashville, TN
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Advantage Clinical Research
mi
from
Nashville, TN
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Tennessee Breast Specialists
mi
from
Nashville, TN
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Tennessee Breast Specialists
mi
from
Nashville, TN
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Dallas Surgical Group
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Dallas Surgical Group
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Leading Edge Research, PA
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Leading Edge Research, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology - Dallas Presbyterian Hospital
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology - Dallas Presbyterian Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology - Memorial City
mi
from
Houston, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology - Memorial City
mi
from
Houston, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Southlake Oncology
mi
from
Southlake, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Southlake Oncology
mi
from
Southlake, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology-Tyler
mi
from
Tyler, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Virginia Oncology Associates
mi
from
Norfolk, VA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Aurora Sinai Medical Center
mi
from
Milwaukee, WI
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Aurora Sinai Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cone Beam Computed Tomography for Breast Imaging
Cone Beam Computed Tomography for Breast Imaging and IV Contrast Enhanced Cone Beam Computed Tomography Breast Imaging
Status: Enrolling
Updated:  1/2/2012
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Cone Beam Computed Tomography for Breast Imaging
Cone Beam Computed Tomography for Breast Imaging and IV Contrast Enhanced Cone Beam Computed Tomography Breast Imaging
Status: Enrolling
Updated: 1/2/2012
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Click here to add this to my saved trials
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
Status: Enrolling
Updated:  1/25/2012
Comprehensive Breast Center at Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
Status: Enrolling
Updated: 1/25/2012
Comprehensive Breast Center at Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
Neoadjuvant Weekly Nab-paclitaxel (Abraxane®) Plus Carboplatin Followed By Doxorubicin Plus Cyclophosphamide With Bevacizumab Added Concurrently To Chemotherapy For Palpable And Operable Triple Negative Invasive Breast Cancer
Status: Enrolling
Updated:  2/1/2012
University of Tennessee Cancer Institute
mi
from
Knoxville, TN
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
Neoadjuvant Weekly Nab-paclitaxel (Abraxane®) Plus Carboplatin Followed By Doxorubicin Plus Cyclophosphamide With Bevacizumab Added Concurrently To Chemotherapy For Palpable And Operable Triple Negative Invasive Breast Cancer
Status: Enrolling
Updated: 2/1/2012
University of Tennessee Cancer Institute
mi
from
Knoxville, TN
Click here to add this to my saved trials
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
Neoadjuvant Weekly Nab-paclitaxel (Abraxane®) Plus Carboplatin Followed By Doxorubicin Plus Cyclophosphamide With Bevacizumab Added Concurrently To Chemotherapy For Palpable And Operable Triple Negative Invasive Breast Cancer
Status: Enrolling
Updated:  2/1/2012
The West Clinic, PC
mi
from
Memphis, TN
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
Neoadjuvant Weekly Nab-paclitaxel (Abraxane®) Plus Carboplatin Followed By Doxorubicin Plus Cyclophosphamide With Bevacizumab Added Concurrently To Chemotherapy For Palpable And Operable Triple Negative Invasive Breast Cancer
Status: Enrolling
Updated: 2/1/2012
The West Clinic, PC
mi
from
Memphis, TN
Click here to add this to my saved trials
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
Neoadjuvant Weekly Nab-paclitaxel (Abraxane®) Plus Carboplatin Followed By Doxorubicin Plus Cyclophosphamide With Bevacizumab Added Concurrently To Chemotherapy For Palpable And Operable Triple Negative Invasive Breast Cancer
Status: Enrolling
Updated:  2/1/2012
The Center for Cancer and Blood Disorders
mi
from
Fort Worth, TX
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
Neoadjuvant Weekly Nab-paclitaxel (Abraxane®) Plus Carboplatin Followed By Doxorubicin Plus Cyclophosphamide With Bevacizumab Added Concurrently To Chemotherapy For Palpable And Operable Triple Negative Invasive Breast Cancer
Status: Enrolling
Updated: 2/1/2012
The Center for Cancer and Blood Disorders
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
A Phase 2 Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
Status: Enrolling
Updated:  2/6/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
A Phase 2 Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
Status: Enrolling
Updated: 2/6/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Breast Cancer Risk Biomarkers in Premenopausal Women
Modulation of Breast Cancer Risk Biomarkers in Premenopausal Women by High Dose Omega-3 Fatty Acids
Status: Enrolling
Updated:  2/6/2012
University of Kansas Medical Center
mi
from
Kansas City, KA
Breast Cancer Risk Biomarkers in Premenopausal Women
Modulation of Breast Cancer Risk Biomarkers in Premenopausal Women by High Dose Omega-3 Fatty Acids
Status: Enrolling
Updated: 2/6/2012
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Fear of Recurrence Pilot Intervention for Women With Breast Cancer
A Pilot Intervention to Address Fear of Recurrence in Breast Cancer Survivors
Status: Enrolling
Updated:  2/7/2012
University of California - San Francisco
mi
from
San Francisco, CA
Fear of Recurrence Pilot Intervention for Women With Breast Cancer
A Pilot Intervention to Address Fear of Recurrence in Breast Cancer Survivors
Status: Enrolling
Updated: 2/7/2012
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Fear of Recurrence Pilot Intervention for Women With Breast Cancer
A Pilot Intervention to Address Fear of Recurrence in Breast Cancer Survivors
Status: Enrolling
Updated:  2/7/2012
University of California - San Francisco
mi
from
San Francisco, CA
Fear of Recurrence Pilot Intervention for Women With Breast Cancer
A Pilot Intervention to Address Fear of Recurrence in Breast Cancer Survivors
Status: Enrolling
Updated: 2/7/2012
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Diet Composition, Weight Control, and Breast Carcinogenesis
Diet Composition, Weight Control, and Breast Carcinogenesis
Status: Enrolling
Updated:  2/9/2012
Rocky Mountain Cancer Center
mi
from
Denver, CO
Diet Composition, Weight Control, and Breast Carcinogenesis
Diet Composition, Weight Control, and Breast Carcinogenesis
Status: Enrolling
Updated: 2/9/2012
Rocky Mountain Cancer Center
mi
from
Denver, CO
Click here to add this to my saved trials
Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer
Phase II Real-Time NIR-Guided Sentinel Lymph Node Mapping in Breast Cancer
Status: Enrolling
Updated:  2/24/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer
Phase II Real-Time NIR-Guided Sentinel Lymph Node Mapping in Breast Cancer
Status: Enrolling
Updated: 2/24/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated:  2/27/2012
Hematology Oncology P.C.
mi
from
Stamford, CT
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated: 2/27/2012
Hematology Oncology P.C.
mi
from
Stamford, CT
Click here to add this to my saved trials
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated:  2/27/2012
Central Georgia Cancer Care
mi
from
Macon, GA
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated: 2/27/2012
Central Georgia Cancer Care
mi
from
Macon, GA
Click here to add this to my saved trials
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated:  2/27/2012
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated: 2/27/2012
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Click here to add this to my saved trials
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated:  2/27/2012
North Shore Cancer Research
mi
from
Skokie, IL
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated: 2/27/2012
North Shore Cancer Research
mi
from
Skokie, IL
Click here to add this to my saved trials
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated:  2/27/2012
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated: 2/27/2012
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated:  2/27/2012
Baystate Medical Center
mi
from
Springfield, MA
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Phase I/II Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Status: Enrolling
Updated: 2/27/2012
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials